milrinone has been researched along with ryanodine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holmberg, SR; Williams, AJ | 1 |
Ichikawa, H; Kawashima, Y; Koide, A; Komai, H; Nakashima, N; Ohashi, T; Shibata, T; Tanaka, K; Yamamoto, F; Yamamoto, H | 1 |
Casadei, B; Musialek, P; Paterson, DJ; Rigg, L; Terrar, DA | 1 |
3 other study(ies) available for milrinone and ryanodine
Article | Year |
---|---|
Phosphodiesterase inhibitors and the cardiac sarcoplasmic reticulum calcium release channel: differential effects of milrinone and enoximone.
Topics: Animals; Calcium Channels; Dose-Response Relationship, Drug; Enoximone; Imidazoles; In Vitro Techniques; Ion Channel Gating; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Ryanodine; Sarcoplasmic Reticulum; Sheep | 1991 |
Harmful effects of inotropic agents on myocardial protection.
Topics: Animals; Body Temperature; Bucladesine; Calcium; Cardiotonic Agents; Creatine Kinase; Diltiazem; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Reperfusion Injury; Pyridones; Rats; Rats, Inbred Strains; Ryanodine | 1991 |
Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
Topics: Animals; Calcium; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Heart Atria; Heart Rate; Hydrazines; Indoles; Isoquinolines; Male; Milrinone; Models, Biological; Molsidomine; Nitric Oxide Donors; Nitrogen Oxides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation Inhibitors; Pyrroles; Quinazolines; Ryanodine; Sarcoplasmic Reticulum; Signal Transduction; Spectrometry, Fluorescence; Sulfonamides; Superoxide Dismutase; Tetrahydroisoquinolines; Thionucleotides; Time Factors; Vasodilator Agents | 2000 |